THERAPEUTICS FOR SUPPRESSING OSTEOPOROSIS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 10, 2015
app pub date -
Feb 21, 2014
filing date -
Feb 21, 2013
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention provides a polypeptide, for use in suppressing or treating osteoporosis, wherein the polypeptide comprises: a non-cytotoxic protease, which protease is capable of cleaving a SNARE protein in an enterochromaffin cell; a Targeting Moiety (TM) that is capable of binding to a Binding Site on an enterochromaffin cell, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the enterochromaffin cell, and wherein said enterochromaffin cell expresses said SNARE protein; and a translocation domain that is capable of translocating the protease from within an endosome, across the endosomal membrane and into the cytosol of the enterochromaffin cell; with the proviso that the polypeptide is not a clostridial neurotoxin (holotoxin) molecule.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully